Publication | Open Access
Phase I Study Assessing the Safety and Tolerability of Barasertib (AZD1152) With Low-Dose Cytosine Arabinoside in Elderly Patients With AML
58
Citations
19
References
2013
Year
Elderly PatientsLow-dose Cytosine ArabinosidePharmacologyClinical TrialsTherapeutic EfficacyClinical PharmacologyPharmacotherapyMedicinePharmacokinetics
| Year | Citations | |
|---|---|---|
Page 1
Page 1